IL-33/ST2/IL-9/IL-9R signaling disrupts ocular surface barrier in allergic inflammation is a research paper published in Mucosal Immunology (2020). On theSindex it has a DataRank of 0.639. It has been cited 70 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.639
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: 5R01EY023598-04
TLR4-DEPENDENT INNATE IMMUNITY IN POLLEN-TRIGGERED OCULAR ALLERGIC INFLAMMATION
NEI NIH HHS
Grant: P30 EY002520
NEI NIH HHS
Grant: R01 EY011915
NEI NIH HHS
Grant: R01 EY023598
FWCI
2.74
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 6 of Development of an ultra-sensitive human IL-33 biomarker assay for age-related macular degeneration and asthma drug development
Additional file 6 of Development of an ultra-sensitive human IL-33 biomarker assay for age-related macular degeneration and asthma drug development
Additional file 5 of Development of an ultra-sensitive human IL-33 biomarker assay for age-related macular degeneration and asthma drug development
Additional file 5 of Development of an ultra-sensitive human IL-33 biomarker assay for age-related macular degeneration and asthma drug development
Additional file 4 of Development of an ultra-sensitive human IL-33 biomarker assay for age-related macular degeneration and asthma drug development
Additional file 4 of Development of an ultra-sensitive human IL-33 biomarker assay for age-related macular degeneration and asthma drug development
Additional file 3 of Development of an ultra-sensitive human IL-33 biomarker assay for age-related macular degeneration and asthma drug development
Additional file 3 of Development of an ultra-sensitive human IL-33 biomarker assay for age-related macular degeneration and asthma drug development
Additional file 2 of Development of an ultra-sensitive human IL-33 biomarker assay for age-related macular degeneration and asthma drug development
Additional file 2 of Development of an ultra-sensitive human IL-33 biomarker assay for age-related macular degeneration and asthma drug development
Additional file 1 of Development of an ultra-sensitive human IL-33 biomarker assay for age-related macular degeneration and asthma drug development
Additional file 1 of Development of an ultra-sensitive human IL-33 biomarker assay for age-related macular degeneration and asthma drug development